Talis Biomedical Corporation Operating Income
Talis Biomedical Corporation reported Operating Income of -$9.58 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-08-19
- Talis Biomedical Corporation operating income (loss) for the quarter ending 2024-06-30 was -$9.58M.
- Talis Biomedical Corporation operating income (loss) for the quarter ending 2024-03-31 was -$14.12M.
- Talis Biomedical Corporation operating income (loss) for the quarter ending 2023-12-31 was -$14.46M.
- Talis Biomedical Corporation operating income (loss) for the quarter ending 2023-09-30 was -$16.97M.
- Talis Biomedical Corporation operating income (loss) for fiscal 2023 was -$66.81M.
- Talis Biomedical Corporation operating income (loss) for fiscal 2022 was -$115.14M.
- Talis Biomedical Corporation operating income (loss) for fiscal 2021 was -$191.82M.
- Talis Biomedical Corporation operating income (loss) for fiscal 2020 was -$91.18M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$9.58M 10-Q · filed 2024-08-19 | -$23.70M 10-Q · filed 2024-08-19 | -$38.15M derived: sum of 3 quarters · filed 2024-08-19 | -$55.12M derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | -$14.12M 10-Q · filed 2024-05-08 | -$28.57M derived: sum of 2 quarters · filed 2024-05-08 | -$45.54M derived: sum of 3 quarters · filed 2024-05-08 | -$61.94M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-12-31 | -$14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$31.43M derived: sum of 2 quarters · filed 2024-03-28 | -$47.82M derived: sum of 3 quarters · filed 2024-08-19 | -$66.81M 10-K · filed 2024-03-28 |
| 2023-09-30 | -$16.97M 10-Q · filed 2023-11-14 | -$33.36M derived: sum of 2 quarters · filed 2024-08-19 | -$52.36M 10-Q · filed 2023-11-14 | -$80.47M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-06-30 | -$16.39M 10-Q · filed 2024-08-19 | -$35.39M 10-Q · filed 2024-08-19 | -$63.50M derived: sum of 3 quarters · filed 2024-08-19 | -$90.29M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$19.00M 10-Q · filed 2024-05-08 | -$47.11M derived: sum of 2 quarters · filed 2024-05-08 | -$73.90M derived: sum of 3 quarters · filed 2024-05-08 | -$101.17M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$28.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$54.90M derived: sum of 2 quarters · filed 2024-03-28 | -$82.17M derived: sum of 3 quarters · filed 2024-03-28 | -$115.14M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$26.79M 10-Q · filed 2023-11-14 | -$54.06M derived: sum of 2 quarters · filed 2023-11-14 | -$87.03M 10-Q · filed 2023-11-14 | -$115.55M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$27.27M 10-Q · filed 2023-08-10 | -$60.24M 10-Q · filed 2023-08-10 | -$88.76M derived: sum of 3 quarters · filed 2023-08-10 | -$127.17M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$32.97M 10-Q · filed 2023-05-11 | -$61.49M derived: sum of 2 quarters · filed 2023-05-11 | -$99.90M derived: sum of 3 quarters · filed 2023-05-11 | -$164.26M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$28.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$66.94M derived: sum of 2 quarters · filed 2023-03-22 | -$131.30M derived: sum of 3 quarters · filed 2023-03-22 | -$191.82M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$38.41M 10-Q · filed 2022-11-03 | -$102.78M derived: sum of 2 quarters · filed 2022-11-03 | -$163.30M 10-Q · filed 2022-11-03 | -$207.48M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$64.36M 10-Q · filed 2022-08-02 | -$124.88M 10-Q · filed 2022-08-02 | -$169.06M derived: sum of 3 quarters · filed 2022-08-02 | -$198.65M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | -$60.52M 10-Q · filed 2022-05-10 | -$104.70M derived: sum of 2 quarters · filed 2022-05-10 | -$134.28M derived: sum of 3 quarters · filed 2022-05-10 | -$144.31M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$44.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$73.77M derived: sum of 2 quarters · filed 2022-03-15 | -$83.79M derived: sum of 3 quarters · filed 2022-03-15 | -$91.18M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$29.58M 10-Q · filed 2021-11-16 | -$39.61M derived: sum of 2 quarters · filed 2021-11-16 | -$47.00M 10-Q · filed 2021-11-16 | |
| 2020-06-30 | -$10.02M 10-Q · filed 2021-08-10 | -$17.42M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$7.39M 10-Q · filed 2021-05-13 |